NDC 51662-1375-01 - FAMOTIDINE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51662-1375
- Requested NDC
- 51662-1375-01
- Package NDCs from labels
- 51662-1375-1, 51662-1375-2, 51662-1375-01
- Manufacturer
- HF Acquisition Co LLC, DBA HealthFirst
- Effective date
- 2022-10-01
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| FAMOTIDINE - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2022-10-01 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51662-1375-1 | FAMOTIDINE | 2 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 2 | 3 | |
| 51662-1375-2 | FAMOTIDINE | 1 in 1 POUCH | INJECTION, SOLUTION | 1 | 3 | |
| 51662-1375-2 | FAMOTIDINE | 2 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 2 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51662-1375 | FAMOTIDINE INJECTION, SOLUTION [HF ACQUISITION CO LLC, DBA HEALTHFIRST] | 3 | Current NDC, Legacy NDC, 3 package rows | 20221002_9948991d-9405-c7c8-e053-2995a90a60ca.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Famotidine | FAMOTIDINE | REMEDYREPACK INC. | 8dbf43e0-856f-443b-b8a4-c69e006878ea | 2026-04-24 | Warnings, Adverse reactions | 5QZO15J2Z8 |
| Acid Controller | FAMOTIDINE | Walgreen Company | 42392cb1-7958-4a2f-8622-f00f02afd961 | 2026-04-24 | Warnings | 5QZO15J2Z8 |
| Mannitol | MANNITOL | Hospira, Inc. | 8ad3145e-00e7-4412-b9a5-06f00f264f30 | 2026-04-21 | Warnings, Adverse reactions | 3OWL53L36A |
| FAMOTIDINE | FAMOTIDINE | Preferred Pharmaceuticals Inc. | b445a613-eaa8-45e8-be1f-5848bfd1dd36 | 2026-04-15 | Warnings, Adverse reactions | 5QZO15J2Z8 |
| Famotidine | FAMOTIDINE | Preferred Pharmaceuticals, Inc. | b1edf3c5-e42c-471b-8771-6c93094822de | 2026-04-15 | Warnings, Adverse reactions | 5QZO15J2Z8 |
| FAMOTIDINE | FAMOTIDINE | Preferred Pharmaceuticals Inc. | dbf94314-3a34-4f03-80b1-296559b7d6a5 | 2026-04-15 | Warnings, Adverse reactions | 5QZO15J2Z8 |
| COMPLETE ACID REDUCER | FAMOTIDINE, CALCIUM CARBONATE, MAGNESIUM HYDROXIDE | CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED | 6ccc03bd-3f36-452a-8945-b3d71cce8241 | 2026-04-08 | Warnings | 5QZO15J2Z8 |
| Ibuprofen and famotidine | IBUPROFEN AND FAMOTIDINE | PHOENIX RX LLC | 4ee3e849-2197-8883-e063-6394a90a1748 | 2026-04-07 | Boxed warning, Warnings, Adverse reactions | 5QZO15J2Z8 |
| acid controller | FAMOTIDINE | CVS Pharmacy | 1531aa51-02e9-45ed-99aa-53b21732dd2e | 2026-04-06 | Warnings | 5QZO15J2Z8 |
| FAMOTIDINE | FAMOTIDINE | REMEDYREPACK INC. | 3ab235f4-da59-4a92-ad6b-c76cf3ecd985 | 2026-04-02 | Warnings, Adverse reactions | 5QZO15J2Z8 |
| Famotidine | FAMOTIDINE | Medical Purchasing Solutions, LLC | 4e803491-8030-50d0-e063-6294a90a5c8d | 2026-04-02 | Warnings, Adverse reactions | 1743833 5QZO15J2Z8 |
| Famotidine | FAMOTIDINE | Bryant Ranch Prepack | 545d5c1f-ec1c-4135-965f-333ad888d96f | 2026-03-31 | Warnings, Adverse reactions | 5QZO15J2Z8 |
| GOOD SENSE DUAL ACTION COMPLETE | FAMOTIDINE, CALCIUM CARBONATE, MAGNESIUM HYDROXIDE | L. Perrigo Company | b5a36da3-7316-493c-b50f-fc5393d858c0 | 2026-03-24 | Warnings | 5QZO15J2Z8 |
| Acid Reducer Maximum Strength | FAMOTIDINE 20MG | Grocery Outlet | 0c85b203-3d09-4799-97a9-722ee207bbfb | 2026-03-20 | Warnings | 5QZO15J2Z8 |
| ACID REDUCER COMPLETE | FAMOTIDINE, CALCIUM CARBONATE, MAGNESIUM HYDROXIDE | Walgreen Company | b94b16d3-b52f-4d70-bbb0-d9fb074c891c | 2026-03-19 | Warnings | 5QZO15J2Z8 |
| Famotidine | FAMOTIDINE | Preferred Pharmaceuticals Inc. | fd5d15b9-b1b5-48ef-ba41-8a43a7642e94 | 2026-03-17 | Warnings, Adverse reactions | 5QZO15J2Z8 |
| acid reducer original strength | FAMOTIDINE | HyVee Inc | a0f2683f-59ad-4f65-a108-696430d577ab | 2026-03-16 | Warnings | 5QZO15J2Z8 |
| Pepcid Complete | FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE | Kenvue Brands LLC | e874118f-b4fe-4c80-aece-99ea20e7e805 | 2026-03-12 | Warnings | 5QZO15J2Z8 |
| complete dual action | FAMOTIDINE, CALCIUM CARBONATE AND MAGNESIUM HYDROXIDE | HyVee Inc | 237efe92-b302-4e11-93fe-7b0f727a00aa | 2026-03-12 | Warnings | 5QZO15J2Z8 |
| ACID REDUCER | FAMOTIDINE | Publix Super Markets Inc | 3455be3c-696e-402a-a5df-830544fa525a | 2026-03-11 | Warnings | 5QZO15J2Z8 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.